CoChat

S100B is selectively expressed by gray matter protoplasmic astrocytes and myelinating oligodendrocytes in the developing CNS

Open access

The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.

Abstract

Studies on the development of central nervous system (CNS) primarily rely on the use of specific molecular markers for different types of neural cells. S100B is widely being used as a specific marker for astrocytes in the CNS. However, the specificity of its expression in astrocyte lineage has not been systematically investigated and thus has remained a lingering issue. In this study, we provide several lines of molecular and genetic evidences that S100B is expressed in both protoplasmic astrocytes and myelinating oligodendrocytes. In the developing spinal cord, S100B is first expressed in the ventral neuroepithelial cells, and later in ALDH1L1+/GS+ astrocytes in the gray matter. Meanwhile, nearly all the S100B+ cells in the white matter are SOX10+/MYRF+ oligodendrocytes. Consistent with this observation, S100B expression is selectively lost in the white matter in Olig2-null mutants in which oligodendrocyte progenitor cells (OPCs) are not produced, and dramatically reduced in Myrf-conditional knockout mutants in which OPCs fail to differentiate. Similar expression patterns of S100B are observed in the developing forebrain. Based on these molecular and genetic studies, we conclude that S100B is not a specific marker for astrocyte lineage; instead, it marks protoplasmic astrocytes in the gray matter and differentiating oligodendrocytes.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s13041-021-00865-9

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 The specificity of S100B antibodies. a–d Sections of P0 mouse spinal cord were subject to anti-S100B immunostaining. The mouse-anti-S100B monoclonal antibodies (green) and rabbit-anti-S100B polyclonal antibodies (red) marked the same population of cells. e, f In situ hybridization against S100b mRNA (f) displayed a nearly identical expression pattern to that of immunostaining (e). Bar, 100 μm
Fig. 1 The specificity of S100B antibodies. a–d Sections of P0 mouse spinal cord were subject to anti-S100B immunostaining. The mouse-anti-S100B monoclonal antibodies (green) and rabbit-anti-S100B polyclonal antibodies (red) marked the same population of cells. e, f In situ hybridization against S100b mRNA (f) displayed a nearly identical expression pattern to that of immunostaining (e). Bar, 100 μmCC BY · PubMed Central
Fig. 2 The expression pattern of S100B in the developing CNS. a–f Sections of E14.5, E16.5, P4, P15, P21 and P72 (adult) mouse spinal cords were subject to anti-S100B immunostaining. S100B+ ventricular cells are indicated with orange arrows (b, c). A few of S100B+ cells were detected both in the white matter (blue arrows) and gray matter (pink arrows) at E16.5 stage (b), but the number increased rapidly at postnatal stages until to P21. g Quantitative comparison of S100B expression in the gray and white matter of spinal cord at different developmental stages. h–k The expression of S100B in P0, P4, P7 and P15 forebrain. Orange arrows indicate the ventricular cells. Higher magnification images in the cortex and corpus callosum were shown in (h′–k′) and (h″–k″), respectively. l, m Quantitative comparison of S100B expression in the corpus callosum and cortex area of forebrain at different developmental stages. sc spinal cord, WM white matter, GM gray matter, DRG dorsal root ganglion, CC corpus callosum. n = 3, *p < 0.05, **p < 0.01. Bar, 100 μm
Fig. 2 The expression pattern of S100B in the developing CNS. a–f Sections of E14.5, E16.5, P4, P15, P21 and P72 (adult) mouse spinal cords were subject to anti-S100B immunostaining. S100B+ ventricular cells are indicated with orange arrows (b, c). A few of S100B+ cells were detected both in the white matter (blue arrows) and gray matter (pink arrows) at E16.5 stage (b), but the number increased rapidly at postnatal stages until to P21. g Quantitative comparison of S100B expression in the gray and white matter of spinal cord at different developmental stages. h–k The expression of S100B in P0, P4, P7 and P15 forebrain. Orange arrows indicate the ventricular cells. Higher magnification images in the cortex and corpus callosum were shown in (h′–k′) and (h″–k″), respectively. l, m Quantitative comparison of S100B expression in the corpus callosum and cortex area of forebrain at different developmental stages. sc spinal cord, WM white matter, GM gray matter, DRG dorsal root ganglion, CC corpus callosum. n = 3, *p < 0.05, **p < 0.01. Bar, 100 μmCC BY · PubMed Central
Fig. 3 S100B is not expressed by neurons. a–c Spinal cord tissues from P4 stage were immunostained simultaneously with S100B and NeuN. Quantitative analysis was showed in (b, c). d–d‴ None of neurons express S100B in different areas of brain tissues. CC corpus callosum. Bar, 100 μm
Fig. 3 S100B is not expressed by neurons. a–c Spinal cord tissues from P4 stage were immunostained simultaneously with S100B and NeuN. Quantitative analysis was showed in (b, c). d–d‴ None of neurons express S100B in different areas of brain tissues. CC corpus callosum. Bar, 100 μmCC BY · PubMed Central
Fig. 4 S100B is expressed in gray matter astrocytes but not white matter GFAP+ astrocytes. a–i Double labeling of S100B with ALDH1L1 and GFAP in the cortical region (a, c, e, h) and corpus callosum (b, d, f, g, i) of forebrain from P4 to adulthood. j–l Double labeling of S100B with ALDH1L1, GS and GFAP in P4 spinal cord. The arrow heads indicate the S100B+ astrocytes, and S100B+ cells that did not express astrocyte marker are indicated by white arrows. m, n Quantitative analysis of S100B expression in astrocytes. sc spinal cord, WM white matter, GM gray matter, CC corpus callosum. n = 3, *p < 0.05, **p < 0.01. Bar, 100 μm
Fig. 4 S100B is expressed in gray matter astrocytes but not white matter GFAP+ astrocytes. a–i Double labeling of S100B with ALDH1L1 and GFAP in the cortical region (a, c, e, h) and corpus callosum (b, d, f, g, i) of forebrain from P4 to adulthood. j–l Double labeling of S100B with ALDH1L1, GS and GFAP in P4 spinal cord. The arrow heads indicate the S100B+ astrocytes, and S100B+ cells that did not express astrocyte marker are indicated by white arrows. m, n Quantitative analysis of S100B expression in astrocytes. sc spinal cord, WM white matter, GM gray matter, CC corpus callosum. n = 3, *p < 0.05, **p < 0.01. Bar, 100 μmCC BY · PubMed Central
Fig. 5 S100B is expressed in the differentiating oligodendrocytes. a–k Co-expression of S100B and SOX10 in mouse CNS tissues. Most S100B+ cells in spinal white matter and a few in the gray matter co-express SOX10 (arrows) (a–c). Similarly, nearly all the S100B+ cells are SOX10+ in the corpus callosum, and SOX10+/S100B+ cells are also presented in the cortex region (arrows) (d–k). White arrow heads refer to SOX10–/S100B+ astrocytes. l–o Co-expression of S100B and MYRF in mouse CNS tissues. Nearly all MYRF+ cells express S100B in P4 spinal white matter and P15 corpus callosum (arrows). p, q Co-expression of S100B and ASPA in brain corpus callosum. ASPA+ mature oligodendrocytes that have completely lost S100B expression are represented by blue arrow heads and ASPA–/S100B+ myelinating oligodendrocytes are indicated by white arrow heads. r–w Quantitative analyses of the co-expression of S100B with SOX10, MYRF and ASPA. sc spinal cord, WM white matter, GM gray matter, CC corpus callosum. n = 3, *p < 0.05, **p < 0.01. Bar, 100 μm
Fig. 5 S100B is expressed in the differentiating oligodendrocytes. a–k Co-expression of S100B and SOX10 in mouse CNS tissues. Most S100B+ cells in spinal white matter and a few in the gray matter co-express SOX10 (arrows) (a–c). Similarly, nearly all the S100B+ cells are SOX10+ in the corpus callosum, and SOX10+/S100B+ cells are also presented in the cortex region (arrows) (d–k). White arrow heads refer to SOX10–/S100B+ astrocytes. l–o Co-expression of S100B and MYRF in mouse CNS tissues. Nearly all MYRF+ cells express S100B in P4 spinal white matter and P15 corpus callosum (arrows). p, q Co-expression of S100B and ASPA in brain corpus callosum. ASPA+ mature oligodendrocytes that have completely lost S100B expression are represented by blue arrow heads and ASPA–/S100B+ myelinating oligodendrocytes are indicated by white arrow heads. r–w Quantitative analyses of the co-expression of S100B with SOX10, MYRF and ASPA. sc spinal cord, WM white matter, GM gray matter, CC corpus callosum. n = 3, *p < 0.05, **p < 0.01. Bar, 100 μmCC BY · PubMed Central
Fig. 6 S100B expression in Olig2-null and Myrf conditional knockout mutants. a, b S100B+ cells were dramatically reduced in E18.5 Olig2-null spinal cord in the white matter, but not in the gray matter. c–j The number of S100B+/SOX10+ oligodendrocytes was significantly reduced in the white matter of spinal cord and forebrain (corpus callosum) in Myrf conditional knockout mutants. k–l Statistical analysis of the number of S100B+ oligodendrocytes in Olig2 and Myrf mutants. SOX10+/S100B+ cells are represented by white arrows. m Schematic diagram of the time window of S100B expression in differentiating oligodendrocytes and gray matter astrocytes. In oligodendrocyte lineage, S100B expression is slightly earlier than that of MYRF, and gradually down-regulated in ASPA+ mature oligodendrocytes. In astrocyte lineage, S100B is gradually up-regulated and maintained in adulthood. sc spinal cord, WM white matter, GM gray matter, CC corpus callosum, OLs oligodendrocytes, OPCs oligodendrocyte progenitor cells, RGCs radial glial cells. n = 3, *p < 0.05, **p < 0.01. Bar, 100 μm
Fig. 6 S100B expression in Olig2-null and Myrf conditional knockout mutants. a, b S100B+ cells were dramatically reduced in E18.5 Olig2-null spinal cord in the white matter, but not in the gray matter. c–j The number of S100B+/SOX10+ oligodendrocytes was significantly reduced in the white matter of spinal cord and forebrain (corpus callosum) in Myrf conditional knockout mutants. k–l Statistical analysis of the number of S100B+ oligodendrocytes in Olig2 and Myrf mutants. SOX10+/S100B+ cells are represented by white arrows. m Schematic diagram of the time window of S100B expression in differentiating oligodendrocytes and gray matter astrocytes. In oligodendrocyte lineage, S100B expression is slightly earlier than that of MYRF, and gradually down-regulated in ASPA+ mature oligodendrocytes. In astrocyte lineage, S100B is gradually up-regulated and maintained in adulthood. sc spinal cord, WM white matter, GM gray matter, CC corpus callosum, OLs oligodendrocytes, OPCs oligodendrocyte progenitor cells, RGCs radial glial cells. n = 3, *p < 0.05, **p < 0.01. Bar, 100 μmCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Cited by

See all 64

Metadata

Authors
Du, J., Yi, M., Zhou, F., He, W., Yang, A., Qiu, M., & Huang, H.
Affiliations
Hangzhou Normal University (CN)
Corresponding author
Huang, Hao
Venue
Molecular Brain
Published
2021-10-06
Volume
14
Issue
1
Pages
154-154
ISSN
1756-6606 (ISSN-L)
OpenAlex
W3202682008
Cited by
57
References
43
Citations by year
2026: 12 · 2025: 13 · 2024: 16 · 2023: 8 · 2022: 7 · 2021: 1
FWCI
2.91
Type
journal article
Language
en
Open access
Licence
Locations
  • Molecular Brain (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Natural Science Foundation of Zhejiang Province (LQ19C090001)
  • National Natural Science Foundation of China (31900703, 31771621)
Topics
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › S100 Proteins and Annexins
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
S100B, protoplasmic astrocyte, myelinating oligodendrocytes, central nervous system development, gray matter, white matter, spinal cord, forebrain, Olig2, MYRF, oligodendrocyte precursor cells, SOX10, ALDH1L1, conditional knockout
MeSH terms
Formyltetrahydrofolate Dehydrogenase, Oxidoreductases Acting on CH-NH Group Donors, Animals, Astrocytes, Brain, Cytoplasm, Glial Fibrillary Acidic Protein, Glutamate-Ammonia Ligase, Myelin Sheath, Neurons, Oligodendroglia, Organ Specificity, RNA, Messenger, Spinal Cord, Biomarkers, Prosencephalon, Cell Lineage, Mice, SOXE Transcription Factors, S100 Calcium Binding Protein beta Subunit, Gray Matter

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: S100B is selectively expressed by gray matter protoplasmic astrocytes and myelinating oligodendrocytes in the developing CNS. https://app.cochat.ai/papers/10.1186/s13041-021-00865-9
The paper
Du, J., Yi, M., Zhou, F., He, W., Yang, A., Qiu, M., & Huang, H. (2021). S100B is selectively expressed by gray matter protoplasmic astrocytes and myelinating oligodendrocytes in the developing CNS. Molecular Brain. https://doi.org/10.1186/s13041-021-00865-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.